Atlas Trials

Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.

Clinical trial NCT02014571 · COMPLETED

Trial details

NCT number
NCT02014571
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis C, Chronic
Start date
2013-12-26
Primary completion
2014-07-03
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.